CareDx, Inc., a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers, reported preliminary financial results for the fourth quarter and full year ended December 31, 2020.
January 11, 2021
· 3 min read
